Ultragenyx Pharmaceutical Inc. Transition Agreements
3 Contracts & Agreements
- Amendment No. 2 dated October 8, 2020 to the Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc. dated as of March 5, 2020, as amended on August... (Filed With SEC on October 13, 2020)
- Amendment dated as of August 28, 2020 to Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc. dated as of March 5, 2020 (Filed With SEC on September 2, 2020)
- Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc., dated March 5, 2020 (Filed With SEC on March 6, 2020)